Examining the Effect of Anti-latency Agents on HIV Epitope Presentation

检查抗潜伏剂对 HIV 表位呈现的影响

• 批准号: 284431
• 负责人: Kuang Xiaomei T
• 金额: $ 0.64万
• 依托单位: Simon Fraser University (Burnaby, B.C.)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-02-01 至 2014-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=284431&lang=en
• 关键词: Anti-Latency Agents; Epitope Presentation; Hiv Reactivation; Hiv-1; Hiv-1 Gag

Highly active antiretroviral therapy (HAART) can effectively treat HIV; however, it must be maintained for life due to HIV's ability to establish reservoirs of latently infected cells that are not affected by antiviral drugs. Recent studies have identifie

高效抗逆转录病毒疗法（HAART）可以有效治疗艾滋病毒；然而，由于艾滋病毒能够建立不受抗病毒药物影响的潜伏感染细胞库，因此必须终生维持这种状态。最近的研究已经确定